The novel p53 isoform "delta p53" is a misfolded protein and does not bind the p21 promoter site

被引:7
|
作者
Garcia-Alai, Maria M. [1 ]
Tidow, Henning [1 ]
Natan, Eviatar [1 ]
Townsley, Fiona M. [1 ]
Veprintsev, Dmitry B. [1 ]
Fersht, Alan R. [1 ]
机构
[1] MRC, Ctr Prot Engn, Cambridge CB2 0QH, England
基金
英国医学研究理事会;
关键词
protein structure/folding; structure/function studies; DNA-binding domains; dominant-negative mutation;
D O I
10.1110/ps.036996.108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor p53 can be expressed as different isoforms because of promoter selection and mRNA editing. One isoform, "delta p53'' (Delta p53), results from what would be an unusual alternative splicing of exons 7/8 of the p53 gene, conserving the reading frame and generating a novel protein with proposed transcriptional activity essential for the intra S-phase checkpoint. Here, we show that the deletion of the 66 residues that correspond to strand beta 10 and the C-terminal helix of the core domain and the interconnecting linker to the tetramerization domain occurring in the Delta p53 isoform leads to a misfolded and unstable protein, prone to form soluble aggregates, which does not bind the p21 promoter site. The complex of coexpressed Delta p53 and flp53 is soluble in vitro and binds poorly to DNA. Our results provide a structural explanation for the dominant-negative effect of Delta p53 and its lack of transcriptional activity.
引用
收藏
页码:1671 / 1678
页数:8
相关论文
共 50 条
  • [21] HBV DNA can bind to P53 protein and influence p53 transactivation in hepatoma cells
    Qu, Jianhui
    Lin, Jing
    Zhang, Shuhui
    Zhu, Zhi
    Ni, Canrong
    Zhang, Shunmin
    Gao, Hengjun
    Zhu, Minghua
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 386 (03) : 504 - 509
  • [22] Detection of the 113p53 protein isoform A p53-induced protein that feeds back on the p53 pathway to modulate the p53 response in zebrafish
    Guo, Lin
    Chua, Joy
    Vijayakumar, Danesh
    Lee, Kian Chung
    Lim, Kathy
    Eng, Huiyan
    Ghadessy, Farid
    Coomber, David
    Lane, David P.
    CELL CYCLE, 2010, 9 (10) : 1998 - 2007
  • [23] Novel nanoparticle fusion protein achieves normal p21 delivery to p53/p21 mutated tumors resulting in their eradication
    Kousparou, Christina
    Stylianou, Spyros
    Deonarain, Mahendra
    Epenetos, Agamemnon
    CANCER RESEARCH, 2009, 69
  • [24] Novel nanoparticle fusion protein achieves normal P21 delivery to p53/p21 mutated tumors resulting in their eradication
    Epenetos, A.
    Kousparou, C.
    Stylianou, S.
    Deonarain, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 123 - 123
  • [25] p53 isoform Δ113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish
    Chen, Jun
    Ng, Sok Meng
    Chang, Changqing
    Zhang, Zhenhai
    Bourdon, Jean-Christophe
    Lane, David P.
    Peng, Jinrong
    GENES & DEVELOPMENT, 2009, 23 (03) : 278 - 290
  • [26] C-terminal region of human p53 attenuates buffalo p53 N-terminal-specific transactivation of p21 promoter by modulating tetramerization of the protein
    Minu Singh
    Tapas Mukhopadhyay
    Molecular and Cellular Biochemistry, 2018, 443 : 101 - 110
  • [27] C-terminal region of human p53 attenuates buffalo p53 N-terminal-specific transactivation of p21 promoter by modulating tetramerization of the protein
    Singh, Minu
    Mukhopadhyay, Tapas
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2018, 443 (1-2) : 101 - 110
  • [28] P16, p21 and p53 expression in penile SCC
    Stankiewicz, E.
    Prowse, D.
    Zhang, X.
    Corbishley, C.
    Berney, D.
    HISTOPATHOLOGY, 2008, 53 : 290 - 291
  • [29] Infrequent expression of p21 is related to altered p53 protein in pancreatic carcinoma
    Hu, YX
    Watanabe, H
    Ohtsubo, K
    Yamaguchi, Y
    Ha, A
    Motoo, Y
    Okai, T
    Sawabu, N
    CLINICAL CANCER RESEARCH, 1998, 4 (05) : 1147 - 1152
  • [30] A novel mechanism of p21 induction by oxaliplatin in p53 deficient cancer cells
    Xu, Weiguo
    Li, Dawei
    CANCER RESEARCH, 2012, 72